Crystallization of IGF-1
0 Assignments
0 Petitions
Accused Products
Abstract
Crystalline IGF-1 is provided along with a method for production thereof. Crystallizing IGF-1 comprises the steps of mixing an aqueous solution comprising IGF-1 with a reservoir solution comprising a precipitant to form a mixture; and crystallizing the mixture, optionally also recrystallizing and isolating the crystalline IGF-1. In addition, a method for identifying IGF-1 indirect agonists is provided using a detergent as a standard for the level of inhibition of binding of IGFBP-1 or IGFBP-3 to IGF-1 and/or using the coordinates of the binding pockets of IGF-1 to which a candidate indirect agonist binds for structure-based drug design.
-
Citations
48 Claims
-
1-42. -42. (canceled)
-
43. A method of designing a compound that mimics the 3-dimensional surface structure of IGF-1 comprising the steps of:
- (a) determining the 3-dimensional structure of the IGF-1; and
(b) designing a compound that mimics the 3-dimensional surface structure of the IGF-1.
- (a) determining the 3-dimensional structure of the IGF-1; and
-
44. A method for identifying a peptidomimetic that binds IGF-1 and blocks binding of an IGFBP or a receptor that binds to IGF-1 comprising the steps of:
- (a) searching a molecular structure database with the structural parameters or structural coordinates provided in Appendix 1; and
(b) selecting a molecule from the database that mimics the structural parameters or structural coordinates of the IGF-1.
- (a) searching a molecular structure database with the structural parameters or structural coordinates provided in Appendix 1; and
-
45. A method for determining at least a portion of a three-dimensional structure of a molecular complex, said complex comprising IGF-1 and said method comprising the steps of:
- (a) determining the structural coordinates of a crystal of IGF-1;
(b) calculating phases from the structural coordinates;
(c) calculating an electron density map from the phases obtained in step (b); and
(d) determining the structure of at least a portion of the complex based on said electron density map. - View Dependent Claims (46)
- (a) determining the structural coordinates of a crystal of IGF-1;
-
47. A method for evaluating the ability of a chemical entity to associate with IGF-1 or a complex thereof, the method comprising the steps of:
- (a) employing computational or experimental means to perform a fitting operation between the chemical entity and the IGF-1 or complex thereof, thereby obtaining data related to the association; and
(b) analyzing the data obtained in step (a) to determine the characteristics of the association between the chemical entity and the IGF-1 or complex thereof.
- (a) employing computational or experimental means to perform a fitting operation between the chemical entity and the IGF-1 or complex thereof, thereby obtaining data related to the association; and
-
48-50. -50. (canceled)
Specification